Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vertex Pharmaceuticals Inc

+ Add to Watchlist

VRTX:US

128.2900 USD 0.8900 0.70%

As of 20:10:00 ET on 05/29/2015.

Company Profile for Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.

Contact Information

Vertex Pharmaceuticals Inc

50 Northern Avenue
Boston, MA 02210
United States
Phone: 1-617-341-6100
Fax: 1-617-444-6680

Key Executives for Vertex Pharmaceuticals Inc (VRTX)

Jeffrey M Leiden "Jeff"President/CEOIan F SmithExec VP/CFO
Stuart A ArbuckleExec VP/Chief Commercial OfcrDavid AltshulerExec VP:Global Research
Jeffrey A Chodakewitz "Jeff"Exec VP:Global Medicines DevAmit K SachdevExec VP:Global Govt Strategy
Kenneth S BogerSenior VP/Secy/Gen CnslPaul M SilvaSenior VP/Controller
Michael PartridgeVP:Investor RelationsKelly LewisDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil